Vial Adaptors for Reconstitution Drug Market is Expanding at an Impressive CAGR of 7.5% During 2016 – 2024

The global Vial Adaptor for Reconstitution Drug Market is fairly consolidated as top four players hold a leading share in the global market. A report by Transparency Market Research states that West Pharmaceutical Services, Inc., Cardinal Health Inc., Baxter International Inc., and Becton, Dickinson & Company collectively held about 67% in the global market in 2015. These companies are expected to focus on enhancing their product portfolio, expanding their geographical presence, and making strategic acquisitions and mergers to stay ahead of the competition in the coming years.

The research report states that the global vial adaptors for reconstitution drug market is expected to be worth US$1.3 bn by the end of 2024 as compared to US$780 mn in 2015. During the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.

The global vial adaptors for reconstitution drug market has been witnessing a spike in demand for products as they are safer options for transferring diluents for reconstitution processes as compared to conventional ways. These also minimize the risk of potential needlestick injury. The market also stands to benefit due to the growing pool of geriatrics, who are susceptible to a wide range of diseases and disorders that require administration of drugs through vial adaptors. Furthermore, the high prevalence of infectious diseases is also likely to augment the demand for reconstitution drugs, which in turn will reflect positively on the demand for vial adaptors required for the same.

Request to View Sample of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18509

The growing demand for lyophilized drugs has also upped the demand for vial adaptors for reconstitution drugs in recent years. The lack of contamination and reduced risk of drug spillage is also expected to drive the rising revenue of the global market all through the forecast period.

The steady pace of market drivers is likely to face a few hurdles during the forecast period. The key restraint in the global vial adaptors for reconstitution drug market is the need for customization for specific products. This demands wide screening of off-the-shelf deployment of vial adaptors, which is the biggest logistical problem for the global market. The demand for vial adaptors for reconstitution drug market is also being hampered by availability of substitutes such as prefilled syringes and auto-injectors.

Vial Adaptors for Reconstitution Drug Market: Reduced Risk of Needlestick Injuries Ups Demand

The research report states that the global vial adaptors for reconstitution drug market is expected to be worth US$1.3 bn by the end of 2024 as compared to US$780 mn in 2015. During the forecast years of 2016 and 2024, the global market is expected to progress at a CAGR of 7.5%.

North America to Show Dominance in Global Market as Technological Advancements Gain Momentum

In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Of these, North America is anticipated to lead the global vial adaptors for reconstitution drug market in the coming years. The fast-paced technological advancements along with rising demand for needle-free products is expected to benefit the North America vial adaptors for reconstitution drug market. By the end of 2024, this regional market is expected to acquire a share of 45.1% in the global market.

The various therapeutic areas studied under this report are autoimmune diseases, metabolic conditions, infectious diseases, reproductive health, and others. Of these, the autoimmune diseases segment accounted for the largest share in the global market in 2015. The segment is anticipated to be exhibit a rapid growth rate due to changing lifestyles, environmental variations impacting human health, and modification of genes through the generations that have spiked the prevalence of autoimmune diseases. The autoimmune diseases segment is expected to progress at a CAGR of 7.5% between 2016 and 2024.

Rising Incidence of Infectious Diseases Augments Demand for Vial Adaptors for Reconstitution Drugs

The global vial adaptors for reconstitution drug market has been witnessing a spike in demand for products as they are safer options for transferring diluents for reconstitution processes as compared to conventional ways. These also minimize the risk of potential needlestick injury. The market also stands to benefit due to the growing pool of geriatrics, who are susceptible to a wide range of diseases and disorders that require administration of drugs through vial adaptors. Furthermore, the high prevalence of infectious diseases is also likely to augment the demand for reconstitution drugs, which in turn will reflect positively on the demand for vial adaptors required for the same.

The growing demand for lyophilized drugs has also upped the demand for vial adaptors for reconstitution drugs in recent years. The lack of contamination and reduced risk of drug spillage is also expected to drive the rising revenue of the global market all through the forecast period.

Difficulty in Customizations Hampers Growth of Global Market

The steady pace of market drivers is likely to face a few hurdles during the forecast period. The key restraint in the global vial adaptors for reconstitution drug market is the need for customization for specific products. This demands wide screening of off-the-shelf deployment of vial adaptors, which is the biggest logistical problem for the global market. The demand for vial adaptors for reconstitution drug market is also being hampered by availability of substitutes such as prefilled syringes and auto-injectors.

Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18509

Vial Adaptors for Reconstitution Drugs Make Medication Administration Safe and Cost-effective

The drive for the demand for vial adaptors stems from the need for safe, cost-effective solutions for the rapid transfer of drugs for the reconstitution. Various technologies used under vial adapters are useful in preventing overfill, reducing exposure to needlestick injuries, and optimizing the entire process of drug reconstitution. The advent of lyophilized drugs, with the benefits of extended shelf-life and reduced time-to-market, in the healthcare system world over and the rising demand for reconstitution medicines among patient populations are noteworthy factors propelling the demand for vial adapters.

Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=18509

The rising demand for technologies for safer administration of reconstitution drugs will offer increased momentum to the growth of the market. Bustling with promising opportunities, the global vial adaptors for reconstitution drugs market is projected to rise at a CAGR of 7.5% during 2016–2024 and reach a worth of US$1.3 billion by the end of the period.

How will rise in incidence of infectious diseases catapult demand for vial adapters?

Key therapeutic areas for the demand for vial adapters comprise autoimmune diseases, infectious diseases, reproductive health, and metabolic conditions. The rising prevalence of chronic conditions, especially in elderly patient populations, is a notable trend contributing to the demand for vial adaptors for reconstitution drugs. This therapeutic area will witness a robust uptake throughout the forecast period, accounting for a major share in the global market. Other area likely to witness substantial demand and uptake is the area of autoimmune diseases. The segment is projected to rise at a prominent pace, fueled by the wide prevalence of autoimmune disorders in populations residing in several developed countries.

West Pharmaceutical Services, Inc. a prominent Pennsylvania-based manufacturer of pharmaceutical packaging and advanced delivery systems, announced on February, 2018, that it is opening a new innovation center in Israel. The injectable drug developer has been in Israel since 2005 and the recent expansion initiative will bring innovations in reconstitution system and needle-free transfer device for safe, quick vial-to-vial transfer.

Which factors make Asia Pacific an attractive region for the uptake of vial adapters?

While North America are Europe are prominent regional market, Asia Pacific is anticipated to offer abundant attractive opportunities. The incessant inroads made by vial adapter technology in the healthcare systems in key economies of the region is supporting the promising growth of the regional market. A strikingly rising diabetic population is further fueling the demand for vial adaptors for reconstitution drugs.

View Report @ https://www.transparencymarketresearch.com/vial-adaptors-for-reconstitution-drug-market.html